Prof Brian HarveyChair of Molecular Medicine, Royal College of Surgeons in Ireland
Brian Harvey is a trained physiologist with a primary degree in physics and physiology and a PhD in physiology and biophysics from the National University of Ireland. After moving to France in 1982 following his PhD, he joined the French National Science Council (CNRS) and became group leader of the membrane transport research team at the Department of Cell and Molecular Biology at the Atomic Energy Commission (CEA) labs in Villefranche-sur-mer. In 1992 he was appointed Professor of Physiology at UCC where he established and directed the Wellcome Trust Cell Physiology Research Unit. Harvey was appointed Vice-president for Research at UCC in 1998-2002. In 2002, Harvey was appointed to the Chair of Molecular Medicine at the Royal College of Surgeons in Ireland and established the Molecular Medicine Laboratories at Beaumont Hospital. In 2004, he was appointed Director of the RCSI Research Institute and in 2005, Director of Research at RCSI. In September 2010 he stepped down from these administrative posts to return to full-time research.
In 2000, Harvey was elected a member of the European Academy of Sciences and Humanities and in 2007 was elected to the Royal Irish Academy. From 2004-2007, he was a founding member and chair of the RIA Life Sciences Committee. In 2005 he received the Laureat Prix Servier from the Servier Institute for his work on rapid responses to steroid hormones. In 2006, Harvey was awarded the Chevalier de l'Ordre National du Merite by The President of France for his role in developing Ireland-France scientific exchanges. Harvey's research is focused on the cellular and molecular physiology of rapid responses to steroid hormones, in particular, the female-specific effects of estrogen in epithelial tissues of lung, kidney and intestine. Another major area of his research concerns the rapid actions in the kidney of the blood-pressure regulating hormone aldosterone.